Form 4 Tracker
Craig C. Hopkinson

EVP R&D, Chief Medical Officer · 11 filings · Latest: Aug 3, 2026

Alkermes plc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ALKS
Craig C. HopkinsonEVP R&D, Chief Medical OfficerFeb 19, 2026
Option Exercise
7,67388,704
ALKS
Craig C. HopkinsonEVP R&D, Chief Medical OfficerFeb 18, 2026
Option Exercise
8,89784,535
ALKS
Craig C. HopkinsonEVP R&D, Chief Medical OfficerFeb 2, 2026
Sale
$33.939,000$305.4K57,740
ALKS
Craig C. HopkinsonEVP R&D, Chief Medical OfficerFeb 2, 2026
Option Exercise
$19.345,000$96.7K66,740
ALKS
Hopkinson Craig C.Feb 2, 2026
Proposed Sale
$33.939,000$305.4K
ALKS
Hopkinson Craig C.Jan 8, 2026
Proposed Sale
$30.005,000$150.0K
ALKS
Hopkinson Craig C.Jan 2, 2026
Proposed Sale
$28.004,000$112.0K
ALKS
Hopkinson Craig C.Dec 3, 2025
Proposed Sale
$30.003,748$112.4K
ALKS
Hopkinson Craig C.Dec 1, 2025
Proposed Sale
$29.304,000$117.2K
ALKS
Hopkinson Craig C.Nov 3, 2025
Proposed Sale
$30.389,000$273.4K
ALKS
Hopkinson Craig C.Oct 15, 2025
Proposed Sale
$31.539,000$283.8K
ALKS
Hopkinson Craig C.Feb 13, 2025
Proposed Sale
$35.53144,419$5.1M
ALKS
Hopkinson Craig C.Feb 12, 2025
Proposed Sale
$32.78204,921$6.7M
ALKS
Hopkinson Craig C.Jan 30, 2025
Proposed Sale
$32.05100,918$3.2M
ALKS
Hopkinson Craig C.Dec 9, 2024
Proposed Sale
$32.0761,151$2.0M
ALKS
Hopkinson Craig C.Dec 5, 2024
Proposed Sale
$31.509,221$290.5K
ALKS
Hopkinson Craig C.Dec 4, 2024
Proposed Sale
$30.7714,349$441.6K
ALKS
Hopkinson Craig C.Nov 11, 2024
Proposed Sale
$30.0858,996$1.8M
ALKS
Hopkinson Craig C.Nov 6, 2024
Proposed Sale
$29.5310,471$309.2K

← Previous

Page 2 of 2